336 related articles for article (PubMed ID: 17123452)
21. Impact of cisplatin administration on protein expression levels in renal cell carcinoma: a proteomic analysis.
Vasko R; Mueller GA; von Jaschke AK; Asif AR; Dihazi H
Eur J Pharmacol; 2011 Nov; 670(1):50-7. PubMed ID: 21924258
[TBL] [Abstract][Full Text] [Related]
22. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
23. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
24. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction.
Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L
Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
[TBL] [Abstract][Full Text] [Related]
26. The proteomic landscape of renal tumors.
Chinello C; L'imperio V; Stella M; Smith AJ; Bovo G; Grasso A; Grasso M; Raimondo F; Pitto M; Pagni F; Magni F
Expert Rev Proteomics; 2016 Dec; 13(12):1103-1120. PubMed ID: 27748142
[TBL] [Abstract][Full Text] [Related]
27. Data-Independent Acquisition-Based Quantitative Proteomic Analysis Reveals Potential Biomarkers of Kidney Cancer.
Song Y; Zhong L; Zhou J; Lu M; Xing T; Ma L; Shen J
Proteomics Clin Appl; 2017 Dec; 11(11-12):. PubMed ID: 28975715
[TBL] [Abstract][Full Text] [Related]
28. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
Yang J; Li X; Tian MJ; Wang LN; Cheng TT; Chen W
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
[TBL] [Abstract][Full Text] [Related]
30. Panel of candidate biomarkers for renal cell carcinoma.
Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
[TBL] [Abstract][Full Text] [Related]
31. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.
Rogers MA; Clarke P; Noble J; Munro NP; Paul A; Selby PJ; Banks RE
Cancer Res; 2003 Oct; 63(20):6971-83. PubMed ID: 14583499
[TBL] [Abstract][Full Text] [Related]
32. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
Park J; Lee EH; Sim H; Na AY; Choi SY; Chung JW; Ha YS; Kwon TG; Lee S; Lee JN
Cancer Genomics Proteomics; 2023; 20(6):592-601. PubMed ID: 37889066
[TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance.
Rajandram R; Yap NY; Pailoor J; Razack AH; Ng KL; Ong TA; Morais C; Gobe GC
Pathology; 2014 Oct; 46(6):518-22. PubMed ID: 25158810
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.
White NM; Newsted DW; Masui O; Romaschin AD; Siu KW; Yousef GM
Tumour Biol; 2014 Mar; 35(3):1833-46. PubMed ID: 24136743
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
[TBL] [Abstract][Full Text] [Related]
36. Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.
Junker H; Venz S; Zimmermann U; Thiele A; Scharf C; Walther R
PLoS One; 2011; 6(7):e21867. PubMed ID: 21760917
[TBL] [Abstract][Full Text] [Related]
37. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
[TBL] [Abstract][Full Text] [Related]
38. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
[TBL] [Abstract][Full Text] [Related]
39. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
Sun CY; Zang YC; San YX; Sun W; Zhang L
Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042
[TBL] [Abstract][Full Text] [Related]
40. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
